Search results
Why Anheuser-Busch InBev Stock Just Popped
Motley Fool via Yahoo Finance· 20 hours agoPreviously, Aujla had a neutral rating on the stock, and a price target of 62.5 euros (about $67.10). What UBS says about Anheuser-Busch
Anheuser-Busch set to deliver ‘ideal’ growth profile, analysts believe
Proactive Investors· 23 hours agoAnheuser-Busch InBev (NYSE:BUD) (ABI) stock moved higher on Monday after the beer maker was upgraded...
Stocks making the biggest moves midday: ResMed, Affirm, Nvidia, Anheuser-Busch and more
CNBC· 23 hours agoCheck out the companies making the biggest moves midday: Inspire Medical Systems , ResMed — Inspire...
Anheuser-Busch InBev SA/NV (NYSE:BUD) Rating Increased to Buy at UBS Group
ETF DAILY NEWS· 1 day agoAnheuser-Busch InBev SA/NV (NYSE:BUD – Get Free Report) was upgraded by stock analysts at UBS Group from a “neutral” rating to a “buy ...
Upgrade Boosts Anheuser-Busch Stock After Extended Drop - Schaeffer's Investment Research
Schaeffers Research· 1 day agoExpert Trader Chris Prybal is no stranger to volatility, and has mastered finding big stock rallies...
Is Anheuser-Busch InBev Sa/NV (NYSE:BUD) the Best Brewery Stock to Invest in?
Insider Monkey via Yahoo Finance· 6 days agoWe recently compiled a list of the 10 Best Alcohol Stocks to Buy Now. Since Anheuser-Busch InBev...
Here's Why Anheuser-Busch Inbev (BUD) is a Strong Value Stock
Zacks via Yahoo Finance· 5 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
How Does The Current Fall In Diageo Stock Compare With That During The 2008 Recession?
Forbes· 1 day agoIn contrast, its peer Anheuser-Busch InBev stock (NYSE: BUD) saw a 2% decline over this period. DEO ...
3 Best Stocks to Buy for Investors Building a Brands Portfolio: 2024 Edition
InvestorPlace· 6 days agoConstellation Brands (NYSE:STZ) is the largest of the three companies on my list with a market...
Stocks making the biggest moves before the bell: Nvidia, Ferrari, Planet Fitness, Cinemark and more
CNBC· 1 day agoResMed tumbled 11.8% following last week's news that Eli Lilly's tirzepatide weight loss drug reduced the severity of obstructive sleep apnea. Eli Lilly, on the other hand, ticked higher by ...